, /PRNewswire/ -- Kvantify, a leading quantum software start-up, has announced the successful closure of a seed round. This funding will enable Kvantify to strengthen its position as a global leader in quantum computing, with an initial focus on developing applications for the life science sector. The investment will accelerate the development of Kvantify's innovative solutions that aim to leverage quantum computing to address complex problems in drug discovery and beyond.
It will also boost the further development of quantum algorithms for chemical simulation, expanding their applicability across various industries. The seed round is notable not only for its substantial size but also for the strategic match of the new investors to Kvantify's mission. It is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and the private investment company 2degrees.
Other notable investors include international sector-focused tech investor Redstone VC, Danish lead quantum VC 2xN as well as EIFO. Lundbeckfonden BioCapital is a large Danish investor focused on local life science companies, supporting the translation and commercialization of ground-breaking science. This is Lundbeckfonden BioCapital's first investment outside the therapeutics space.
"With our investment in Kvantify, we are broadening our footprint in and commitment to further strengthening the Danish life science ecosystem. Quantum computing can deliver accuracy and derisking to the early sta.